Hubungan Kepatuhan Penggunaan Obat Inhaler (B2-Agonis + Kortikosteroid Inhalasi) dengan Kualitas Hidup Pasien Asma di RSUD Dr. Suhatman Mars Dumai dinilai Dengan Mars-5 dan M-aqlq
Abstract
Asthma is a heterogeneous disease usually characterized by chronic airway inflammation. The disease is defined by a history of respiratory symptoms such as wheezing, shortness of breath, chest tightness, and coughing, which vary over time and intensity, as well as different expiratory airflow limitations. Asthma treatment can be classified as controllers or relievers where the goal of asthma treatment is to improve and maintain the quality of life of asthma patients so that they can live a normal life and perform their daily activities without hindrance. Asthma treatment should consider both the giver and receiver of the medication, including patient compliance. Patient adherence to medication is an important component of asthma treatment. Thus, improving adherence greatly impacts lung function improvement, while non-adherence will reduce quality of life and increase treatment costs. Asthma patients' quality of life can suffer if they are not adherent to their medication, which can limit their daily activities, such as exercising, not going to school, and missing work days. The disease can also cause physical, emotional, and social limitations that impact the patient's education and career. This study aimed to determine the relationship between compliance with the use of inhaler drugs (β2- agonists + Inhaled Corticosteroids) to the quality of life of asthmatics at RSUD dr. Suhatman MARS. This study was a correlation analytic design with a cross-sectional approach. The research design used a quantitative plan. This research was conducted at dr. Suhatman Hospital MARS in Dumai City. Sampling technique using Purposive Sampling. There is a relationship between medication adherence and quality of life of asthma patients at dr. Suhatman MARS Hospital with a p-value of 0.000 and a correlation coefficient of 0.621. Adherence to medication use has a relationship with the quality of life of asthma patients at RSUD dr. Suhatman MARS Dumai City.
References
[2] GINA, Global Strategy for Asthma Management and Prevention. United States of America: Global Initiative for Asthma, 2022.
[3] WHO, “Asthma,” World Health Organization, 2023.
[4] Kemenkes RI, “Asma,” Kementerian Kesehatan Republik Indonesia, 2022.
[5] Riskesdas, “Laporan Riset Kesehatan Dasar Provinsi Riau,” Jakarta, 2018.
[6] H. K. Reddel et al., “Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes,” Eur. Respir. J., vol. 59, no. 1, 2022, doi: 10.1183/13993003.02730-2021.
[7] Depkes RI, Pedoman Pengendalian Penyakit Asma. Jakarta: Departemen Kesehatan RI, 2008.
[8] PDPI, ASMA, 3rd ed. Jakarta: Perhimpunan Dokter Paru Indonesia, 2021.
[9] Nuryati, Bahan Ajar Rekam Mdis dan Informasi Kesehatan (RMIK) Farmakologi, 1st ed. Jakarta: Kemenkes RI, 2017.
[10] Susilo, “Program studi di farmasi sekolah tinggi ilmu kesehatan nasional surakarta 2019,” Sekolah TInggi Ilmu Kesehatan Nasional Surakarta, 2019.
[11] H. Lycett, E. Wildman, E. Raebel, J. Sherlock, and T. Kenny, “Treatment Perceptions in Patients with Asthma: Synthesis of Factors Influencing Adherence,” Respir. Med., 2018, doi: 10.1016/j.rmed.2018.06.032.
[12] S. Haryanti, Z. Ikawati, and T. M. Andayani, “Hubungan Kepatuhan Menggunakan Obat Inhaler β2-Agonis dan Kontrol Asma pada Pasien Asma,” vol. 5, no. 4, pp. 238–248, 2016, doi: 10.15416/ijcp.2016.5.4.238.
[13] M. J. Supianto, “Naskah publikasi hubungan derajat asma persisten dan kualitas hidup pasien asma dinilai dengan,” p. 13, 2015.
[14] N. I. Lestari and F. Lestari, “Evaluasi Kualitas Hidup Penderita Asma di Kabupaten Belitung,” Pros. Farm., vol. 7, no. 2, 2021, doi: http://dx.doi.org/10.29313/.v0i0.29185.
[15] I. Afiani, A. Salam, and Effiana, “Faktor – Faktor yang Mempengaruhi Kualitas Hidup Pasien Asma Dewasa di Unit Pengobatan Penyakit Paru-Paru Pontianak Periode Januari – Juni 2015,” J. Cerebellum, vol. 3, no. 2, pp. 754–769, 2017.
[16] A. Muslimah, R. Rahmawati, and Charles Banon, “Tingkat Kepatuhan Penggunaan Obat Asma di Apotek Sehat Bersama 1 Kota Bengkulu,” Bencoolen J. Pharm., vol. 3, no. 1, pp. 41–49, 2023.
[17] S. Lukas, H. Nugroho, and J. P, “Analisis Hubungan Kepatuhan Penggunaan Obat Antiasma dengan Kualitas Hidup PAsien Asma Persisten Rawat Jalan di RSUP Persahabatan Jakarta Periode Juli-Agustus 2017,” Soc. Clin. Pharm. Indones. J., vol. 2, no. 2, pp. 1–14, 2017.
[18] R. Chaidir and M. S. Septika, “Hubungan Dreajat Asma dengan Kualitas Hidup yang dinilai dengan Asthma Quaty of Life Questionnaire di Ruang Poliklinik Paru RSUD dr. Achmad Mochtar,” J. Ilmu Kesehat. ’Afiyah, vol. 2, no. 1, 2014.
[19] A. S. Wahyuni, R. Z. Hamid, T. Syafiuddin, A. Bachtiar, and N. Nerdy, “The Correlation between Adherence and Asthma Patients Quality of Life in Medan , Indonesia,” vol. 6, no. 11, pp. 2198–2205, 2018, doi: https://doi.org/10.3889/oamjms.2018.362.
[20] L. D. Fitri, J. Marlindawani, and A. Purba, “Kepatuhan Minum Obat pada Pasien Tuberkulosis Paru,” J. Ilmu Kesehat. Masy., vol. 07, no. 01, pp. 33–42, 2018, doi: https://doi.org/10.33221/jikm.v7i01.50.
[21] C. S. Burckhardt and K. L. Anderson, “The Quality of Life Scale ( QOLS ): Reliability , Validity , and,” vol. 7, pp. 1–7, 2003, doi: 10.1186/1477-7525-1-60.
Copyright (c) 2025 Octariany, Dewi Murni Manihuruk, Mhd. Wahyudi Azmi

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.








